Top 5 papers in medicine, 2010

The year's most highly ranked articles in all of medicine, according to the Faculty of 1000

By | December 22, 2010

Which treatment works best under which conditions? It's one of the most important questions medical researchers ever ask, and this year is no exception. Studies of treatment options for a type of lung cancer, how far to lower blood pressure in diabetics, and surgical or non-surgical options for stenosis all topped this year's list of the most important papers in the medical field, as reviewed and ranked by members of the Faculty of 1000. linkurl:5. Early palliative care helps in advanced cancer; linkurl:The paper:; J.S. Temel, et al., "Early palliative care for patients with metastatic non-small-cell lung cancer," N Engl J Med, 363:733-42, 2010.
Patients with inoperable, metastatic non-small-cell lung cancer may benefit from early palliative care, reporting a better quality of life, and less depression than those who did not receive palliative care. Median survival also improved in those receiving early palliative care, even though they were less likely to receive aggressive treatment at the end of their lives. linkurl:4. Skip the surgery?; linkurl:The paper:; M.B. Leon, et al., "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery," N Engl J Med, 2010. A new, nonsurgical treatment for patients with severe aortic stenosis, a type of heart disease characterized by the narrowing of the aortic valve opening, may provide an alternative for patients who are not candidates for open-heart surgery. The treatment, known as transcatheter aortic-valve implantation -- which replaces the aortic valve through a catheter -- was associated with 20 percent lower mortality, as well as reduced rates of hospitalization and cardiac symptoms. However, the procedure also resulted in a higher incidence of major strokes and vascular complications. linkurl:3. In diabetes, less is not always more; linkurl:The paper:; W.C. Cushman, et al., "Effects of intensive blood-pressure control in type 2 diabetes mellitus," N Engl J Med, 362:1575-85, 2010. Contrary to expectations, in type 2 diabetes, a normal blood pressure (with systolic levels below 120 mm Hg) is not associated with a fewer cardiovascular events than a slightly above-normal blood pressure of 140 mm Hg or below, forcing clinicians to reevaluate blood pressure goals in these patients. linkurl:2. Drug helps - not hurts - in serious lung disease; linkurl:The paper:; L. Papazian, et al., "Neuromuscular blockers in early acute respiratory distress syndrome," N Engl J Med, 363:1107-16. 2010. Doctors have hesitated to give neuromuscular blocking agents to patients with the life-threatening lung condition called acute respiratory distress syndrome, out of fear the drugs could cause muscle weakness. But a clinical trial found patients who took a neuromuscular blocker were more likely than those on a placebo to survive 90 days, and showed no increase in muscle weakness. (Some faculty members, however, disagreed with the paper's conclusions, arguing narcotics are more appropriate in these patients.) linkurl:1. To stent or not; linkurl:The paper:; T.G. Brott, et al., "Stenting versus endarterectomy for treatment of carotid-artery stenosis," N Engl J Med, 363:11-23, 2010. A large randomized trial demonstrates that stenting and surgical clearing of arteries are safe and equally effective ways of treating the narrowing of the carotid arteries, called stenosis.
**__Related stories:__***linkurl:Top 5 papers of 2010;
[9th December 2010]*linkurl:The five hottest biology papers of 2009;
[17th December 2009]


Avatar of: Mike Waldrep

Mike Waldrep

Posts: 155

December 23, 2010



Posts: 1

December 23, 2010

... a morbid, skewed and unfortunate view of our times?\n\n2 x CVD\n1 x cancer\n1 x diabetes\n1 x 340 patient and 100+(!!!)-author study (cisatracurium besylate / GlaxoSmithKline's Nimbex® vs. placebo).\n\n"Which treatment is unnecessary and conditions which are preventable?" ... Will the learned Faculty find this too bland?\n\nMight they identify:\n\nA simple method of supplementation of omega-3 polyunsaturated Fatty acids: use of fortified yogurt in healthy volunteers.\n\nMcCowen KC, Ling PR, Decker E, Djordjevic D, Roberts RF, Coupland JN, Bistrian BR.\n\nNutr Clin Pract. 2010 Dec;25(6):641-5.\nPMID: 21139129\n\ntogether with ...\n\nDietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial.\n\nSmith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B.\n\nAm J Clin Nutr. 2010 Dec 15. PMID: 21159787\n\nor a challenging idea with far reaching implications:\n\nK. Atarashi, et al., "Induction of colonic regulatory T cells by indigenous Clostridium species," ScienceExpress, 10.1126/science. 1198469, 2010.\n\n... and from among so many, many more?\n\nHeraclitus of Ephesus [c. 535?c. 475 BCE] will remind us:\n\n?Doctors cut, burn, and torture the sick, and then demand of them an undeserved fee for such services?\n\n?Much learning does not teach understanding.?\n\nbut also encourage all to reconsider, for ...\n\n?Man is not made for defeat?\n\nand \n\n?Opposition brings concord. Out of discord comes the fairest harmony.?\n\n\n\nAnd particularly Re. No 2. 'Drug helps - not hurts - in serious lung disease': Thomas Kuhn, is certain to add "... when the effort expended on a problem increases ? yet productivity declines ? then the difficulty may lie with the assumptions".\n

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs